The role of MT2-MMP in cancer progression

Biochemical and Biophysical Research Communications

Volumn 393, Issue 2, 2010, Pages 222-227

  Ito, Emiko ^a   Yana, Ikuo ^a,b   Fujita, Chisato ^a   Irifune, Aiko ^a   Takeda, Maki ^a   Madachi, Ayako ^a   Mori, Seiji ^a   Hamada, Yoshinosuke ^a   kawaguchi, Naomasa ^a   Matsuura, Nariaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Invasion; Migration; MT2 MMP; Proliferation

Indexed keywords

MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TUMOR CELL;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; HUMANS; MATRIX METALLOPROTEINASE 15; NEOPLASM INVASIVENESS; NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

MUS MUSCULUS;

EID: 77649184658     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.01.105     Document Type: Article

References (22)

1. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
2. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
3. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., and Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370 (1994) 61-65
4. Tanimura S., Asato K., Fujishiro S.H., and Kohno M. Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44. Biochem. Biophys. Res. Commun. 304 (2003) 801-806
5. Hotary K.B., Yana I., Sabeh F., Li X.Y., Holmbeck K., Birkedal-Hansen H., Allen E.D., Hiraoka N., and Weiss S.J. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and independent processes. J. Exp. Med. 195 (2002) 295-308
6. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 194 (2003) 1-11
7. Holmbeck K., Bianco P., Yamada S., and Birkedal-Hansen H. MT1-MMP: a tethered collagenase. J. Cell. Physiol. 200 (2004) 11-19
8. Sounni N.E., and Noel A. Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87 (2005) 329-342
9. Sato H., Takino T., and Miyamori H. Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci. 96 (2005) 212-217
10. Ueno H., Nakamura H., Inoue M., Imai K., Noguchi M., Sato H., Seiki M., and Okada Y. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 57 (1997) 2055-2060
11. Morrison C.J., and Overall C.M. TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains. J. Biol. Chem. 281 (2006) 26528-26539
12. Hotary K., Allen E., Punturieri A., Yana I., and Weiss S.J. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149 (2000) 1309-1323
13. Nonaka T., Nishibashi K., Itoh Y., Yana I., and Seiki M. Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase14 in vivo. Mol. Cancer Ther. 4 (2005) 1157-1166
14. Ochiai A., Yokozaki H., Kyo E., Hozumi T., and Tahara E. A monoclonal antibody reacting with various human carcinomas and fetal colon and esophagus. Jpn. J. Cancer Res. 76 (1985) 915-918
15. Hotary K.B., Allen E.D., Brooks P.C., Datta N.S., Long M.W., and Weiss S.J. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114 (2003) 33-45
16. Sabeh F., Ota I., Holmbeck K., Brikedal-hansen H., Soloway P., Balbin M., Lopez-otin C., Shapiro S., Inada M., Krane S., Allen E., Chung D., and Weiss S.J. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 167 (2004) 769-781
17. Fisher K.E., Pop A., Koh W., Anthis N.J., Saunders W.B., and Davis G.E. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. Mol. Cancer 5 (2006) 69
18. Li X.Y., Ota I., Yana I., Sabeh F., and Weiss S.J. Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase. Mol. Biol. Cell 19 (2008) 3221-3233
19. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., and Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J. Biol. Chem. 270 (1995) 5331-5338
20. Ueda J., Kajita M., Suenaga N., and seiki M. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene 22 (2003) 8716-8722
21. Hernandez-Barrantes S., Shimura Y., Soloway P.D., Sang Q.A., and Fridman R. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP. Biochem. Biophys. Res. Commun. 281 (2001) 126-130
22. Rebustini I.T., Myers C., Lassiter K.S., Surmak A., Szabova L., Holmbeck K., Pedochenko V., Hudson B.G., and Hoffman M.P. MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis. Dev. Cell 17 (2009) 482-493